A novel AR splice variant, AR8, was found to be localized to the plasma membrane via palmitoylation at Cys588 and Cys560, and overexpression of AR8 reduced prostate cancer cell proliferation and enhanced apoptosis in androgen‐depleted culture conditions [38] (Fig. 2, Table 1). This evidence concerns the gene AR and prostate cancer.